Skip to main content

Table 3 Hazard ratio and 95%CI for proportional hazard models assessing the effect of variables associated with survival (univariate analysis)

From: Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer

 

Coefficient (SE)

Hazard ratio (95%CI)

p

BMI < =21

0.51 (0.25)

1.67 (1.03–2.73)

0.037

NRI < =97.5

0.54 (0.25)

1.71 (1.04–2.81)

0.033

WHO Score*

− 0.47 (0.23)

0.63 (0.4–0.99)

0.044

Sarcopenia****

0.96 (0.24)

2.61 (1.61–4.24)

< 0.001

Weight loss<=5%

−0.35 (0.24)

0.71 (0.44–1.13)

0.142

Weight loss<=10%

−0.13 (0.26)

0.88 (0.53–1.45)

0.604

Albumin levels<=35(g/l)

−0.23 (0.31)

0.79 (0.43–1.45)

0.449

BMI < =18

0.61 (0.33)

1.84 (0.96–3.53)

0.061

Masculine Sex

0.53 (0.34)

1.7 (0.87–3.3)

0.116

Age < =65

−0.3 (0.23)

0.74 (0.47–1.16)

0.186

Histology ***

0.32 (0.29)

1.38 (0.77–2.47)

0.277

SUV max<=12.3

−0.33 (0.23)

0.72 (0.46–1.13)

0.154

TVol40 < =9.9

−0.44 (0.28)

0.64 (0.37–1.12)

0.116

Muscular Mean Density < =41 (for BMI < 25)

0.02 (0.43)

1.02 (0.43–2.41)

0.957

Muscular Mean Density < =33 (for BMI > 25)

1.11 (0.74)

3.02 (0.71–12.82)

0.116

Metastasis **

−0.33 (0.33)

0.72 (0.38–1.37)

0.315

  1. *Versus patients with WHO score > 0. ** Versus patient without metastasis. ***SCC versus OA. **** Defined as SMI < 38.3 cm2/m2 for women and < 52.4 cm2/m2 for men